Publication | Closed Access
First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults
190
Citations
38
References
2015
Year
VaccinationPulmonary TuberculosisTuberculosis PreventionImmunologyMycobacterium TuberculosisVaccine TestingTuberculosisVaccine EfficacyPreventive TreatmentInfection ControlNon-infected Healthy AdultsMedicineVaccine ResearchFirst-in-human Trial
| Year | Citations | |
|---|---|---|
1999 | 5.7K | |
1999 | 1.5K | |
2002 | 1.4K | |
2011 | 520 | |
2004 | 447 | |
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics Laith J. Abu‐Raddad, Lorenzo Sabatelli, Jerusha T. Achterberg, Proceedings of the National Academy of Sciences Tuberculosis PreventionVaccine HesitancyPreventive MedicineMelinda Gates FoundationVaccine Surveillance | 2009 | 354 |
2006 | 329 | |
2005 | 315 | |
2008 | 285 | |
2012 | 268 |
Page 1
Page 1